Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pylera plus omeprazole for Helicobacter pylori eradication after prior eradication treatment failure
2010-019064-36Phase 3Completed
- Sponsor
- Axcan Pharma Inc.
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride and omeprazole in Helicobacter pylori infection, sponsored by Axcan Pharma Inc. Primary endpoint: Helicobacter pylori eradication rate. Started Nov 2011; status: completed.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochlorideomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on 2010-019064-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019064-36.